When pregabalin is being considered to treat fibromyalgia pain, which of the following applies?
A. This drug is not indicated in fibromyalgia, thus should not be used
B. It can be used only with an opioid
C. It works best when used with NSAIDs
D. B and C
E. None of the above
Ans: E. None of the above
You might also like to view...
The nurse is assessing an obese patient who expresses an interest in bariatric surgery
The nurse knows that in addition to meeting the criterion of morbid obesity, a candidate for bariatric surgery must also demonstrate which of the following? A) Knowledge of the causes of obesity and its associated risks B) Emotional stability and understanding of required lifestyle changes C) Positive body image and high self-esteem D) Insight into why their past weight loss efforts failed
A patient states, "My doctor said sometimes I may have an on-and-off problem with this medication. What does that mean?" How should the nurse respond?
1. "The on times will be when your symptoms are under control; the off times are when you will have increased problems with symptom management.". 2. "There will be times when you are depressed (off) and when you are happy (on).". 3. "You will have to take breaks from this medicine by stopping (off) and starting it (on) again so you don't build up a tolerance to it.". 4. "The off-on phases are associated with your appetite.".
Phantom pain is: a. the sensation of pain from a body part that hasbeen removed
b. pain that is not real. c. a type of ghost pain that mimics pain in thealternative limb. d. a type of referred pain.
In the context of the drugs used to treat bone disorders, which of the following is true of bisphosphonates?
A. Bisphosphonates are used to stimulate bone resorption in men and women. B. Bisphosphonates are analogs of endogenous pyrophosphates that have a special attraction to calcium in bones. C. Bisphosphonates are well absorbed by the gastrointestinal tract. D. The nitrogen-bisphosphonates have lesser resorption inhibition potency than non-nitrogen bisphosphonates.